Kyle Moran - 05 Feb 2026 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role: Chief Financial Officer
Signature: /s/ Kyle Moran
Issuer symbol: WVE
Transactions as of: 05 Feb 2026
Net transactions value: -$48,259
Form type: 4
Filing time: 11 Feb 2026, 21:03:07 UTC
Previous filing: 10 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Moran Kyle	Chief Financial Officer	C/O WAVE LIFE SCIENCES LTD.,, 733 CONCORD AVE., CAMBRIDGE	/s/ Kyle Moran	11 Feb 2026	0001657765

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WVE	Ordinary Shares	Award	$0	+45,625	+49%	$0.000000	137,973	05 Feb 2026	Direct	F1, F2
transaction	WVE	Ordinary Shares	Sale	$48,259	-3,588	-2.6%	$13.45	134,385	09 Feb 2026	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WVE	Share Option (right to buy)	Award	$0	+273,750		$0.000000	273,750	05 Feb 2026	Ordinary Shares	273,750	$12.75	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2027 through February 8, 2030.
F2	Includes 1,983 ordinary shares acquired on January 14, 2026, under the issuer's 2019 Employee Share Purchase Plan.
F3	On February 9, 2026, the reporting person sold 3,588 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 8, 2026. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
F4	The option vests as to 25% of the shares on February 8, 2027, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2030.